Progress, in the open.

Platform

Ab-LNP_mRNA in-situ cell engineering platform reaches validation milestone

Internal studies confirm that the simplified stable labelling process preserves particle integrity and antibody avidity through formulation and storage, completing platform-level validation of the mRNA arm.

Science

Second payload: Ab-LNP_CRISPR gene editing platform enters development

The company has started development of an sgRNA payload for in-situ gene editing on the same Ab-LNP backbone, extending the platform from expression to correction.

Company

Promax Bioscience begins build-out of AI-driven R&D management system

A six-layer architecture connecting laboratory instruments, data governance, applications and AI-based decision management is now in phased implementation.